|
A healthcare professional reported that a patient reported that a patient was injected in the ck1, ck2, and ck 3 using juvéderm® voluma¿ xc and juvéderm® vollure¿ xc the patient developed nodules in the marionette.Additionally, the healthcare professional reported that the patient was injected with juvéderm® voluma¿ xc in the ck1, ck2, and ck3, and 1 ml of juvéderm® vollure¿ xc in the m1, m2, m3 the patient developed nodules and tenderness.The hcp treated the patient with hylenex a year ago, and the next treatment was 5 months ago.The symptoms have resolved.
|
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was discarded.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|